Usp7 protects genomic stability by regulating Bub3

Oncotarget

Volumn 5, Issue 11, 2014, Pages 3728-3742

  Giovinazzi, Serena ^a,b   Sirleto, Pietro ^c   Aksenova, Vasilisa ^d   Morozov, Viacheslav M ^a,b   Zori, Roberto ^a   Reinhold, William C ^e   Ishov, Alexander M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d INSTITUTE OF CYTOLOGY   (Russian Federation)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bub3; Deubiquitinase USP7; Genomic instability; Spindle assembly checkpoint (SAC); USP7 inhibitors

Indexed keywords

BUB3 PROTEIN; CYCLIN B; DEUBIQUITINASE; UBIQUITIN SPECIFIC PROCESSING PROTEASE 7; UNCLASSIFIED DRUG; BUB3 PROTEIN, HUMAN; CELL CYCLE PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; GENETIC STABILITY; GENOMIC INSTABILITY; M PHASE CELL CYCLE CHECKPOINT; MICRONUCLEUS; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HUMAN; METABOLISM; NEOPLASM;

CELL CYCLE PROTEINS; GENE EXPRESSION; GENOMIC INSTABILITY; HCT116 CELLS; HEK293 CELLS; HUMANS; NEOPLASMS; TRANSFECTION; UBIQUITIN THIOLESTERASE;

EID: 84903542730     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1989     Document Type: Article

References (78)

1. Rajagopalan H and Lengauer C. Aneuploidy and cancer. Nature. 2004; 432(7015):338-341.
2. Kolodner RD, Cleveland DW and Putnam CD. Cancer. Aneuploidy drives a mutator phenotype in cancer. Science. 2011; 333(6045):942-943.
3. Kops GJ, Weaver BA and Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005; 5(10):773-785.
4. Weaver BA and Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol. 2006; 18(6):658-667.
5. Weaver BA and Cleveland DW. The role of aneuploidy in promoting and suppressing tumors. J Cell Biol. 2009; 185(6):935-937.
6. Duesberg P, Fabarius A and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life. 2004; 56(2):65-81.
7. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-674.
8. Pinsky BA and Biggins S. The spindle checkpoint: tension versus attachment. Trends Cell Biol. 2005; 15(9):486-493.
9. Carmena M and Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 2003; 4(11):842-854.
10. Maresca TJ and Salmon ED. Welcome to a new kind of tension: translating kinetochore mechanics into a waitanaphase signal. J Cell Sci. 2010; 123(Pt 6):825-835.
11. Musacchio A and Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol. 2007; 8(5):379-393.
12. Rao CV, Yamada HY, Yao Y and Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis. 2009; 30(9):1469-1474.
13. Meraldi P, Draviam VM and Sorger PK. Timing and checkpoints in the regulation of mitotic progression. Dev Cell. 2004; 7(1):45-60.
14. Losada A, Hirano M and Hirano T. Cohesin release is required for sister chromatid resolution, but not for condensin-mediated compaction, at the onset of mitosis. Genes Dev. 2002; 16(23):3004-3016.
15. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N and van Deursen JM. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol. 2003; 160(3):341-353.
16. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M and Rao CV. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 2004; 64(2):440-445.
17. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV and Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 2001; 409(6818):355-359.
18. Weaver BA and Cleveland DW. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 2007; 67(21):10103-10105.
19. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P and Cleveland DW. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell. 2007; 11(1):25-36.
20. Baker DJ, Jin F, Jeganathan KB and van Deursen JM. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell. 2009; 16(6):475-486.
21. Jeganathan K, Malureanu L, Baker DJ, Abraham SC and van Deursen JM. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol. 2007; 179(2):255-267.
22. Hoyt MA, Totis L and Roberts BT. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 1991; 66(3):507-517.
23. Martinez-Exposito MJ, Kaplan KB, Copeland J and Sorger PK. Retention of the BUB3 checkpoint protein on lagging chromosomes. Proc Natl Acad Sci U S A. 1999; 96(15):8493-8498.
24. Braunstein I, Miniowitz S, Moshe Y and Hershko A. Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint. Proc Natl Acad Sci U S A. 2007; 104(12):4870-4875.
25. Tang Z, Shu H, Oncel D, Chen S and Yu H. Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol Cell. 2004; 16(3):387-397.
26. Logarinho E and Bousbaa H. Kinetochore-microtubule interactions "in check" by Bub1, Bub3 and BubR1: The dual task of attaching and signalling. Cell Cycle. 2008; 7(12):1763-1768.
27. Logarinho E, Resende T, Torres C and Bousbaa H. The human spindle assembly checkpoint protein Bub3 is required for the establishment of efficient kinetochoremicrotubule attachments. Mol Biol Cell. 2008; 19(4):1798-1813.
28. Kalitsis P, Earle E, Fowler KJ and Choo KH. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev. 2000; 14(18):2277-2282.
29. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J and PandolfiPP. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature. 2008; 455(7214):813-817.
30. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J and Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002; 416(6881):648-653.
31. Cummins JM and Vogelstein B. HAUSP is required for p53 destabilization. Cell cycle. 2004; 3(6):689-692.
32. Faustrup H, Bekker-Jensen S, Bartek J, Lukas J and Mailand N. USP7 counteracts SCFbetaTrCP-but not APCCdh1-mediated proteolysis of Claspin. J Cell Biol. 2009; 184(1):13-19.
33. van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM and Burgering BM. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol. 2006; 8(10):1064-1073.
34. Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, Rich JN and Bao S. Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol. 2011; 13(2):142-152.
35. Boutell C, Canning M, Orr A and Everett RD. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J Virol. 2005; 79(19):12342-12354.
36. Canning M, Boutell C, Parkinson J and Everett RD. A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J Biol Chem. 2004; 279(37):38160-38168.
37. Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 1997; 16(7):1519-1530.
38. Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, Greenblatt J and Frappier L. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitinspecific protease HAUSP/USP7. J Biol Chem. 2003; 278(32):29987-29994.
39. Jager W, Santag S, Weidner-Glunde M, Gellermann E, Kati S, Pietrek M, Viejo-Borbolla A and Schulz TF. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA. J Virol. 2012; 86(12):6745-6757.
40. Sarkari F, Sanchez-Alcaraz T, Wang S, Holowaty MN, Sheng Y and Frappier L. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 2009; 5(10):e1000624.
41. van der Knaap JA, Kozhevnikova E, Langenberg K, Moshkin YM and Verrijzer CP. Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Mol Cell Biol. 2010; 30(3):736-744.
42. van der Knaap JA, Kumar BR, Moshkin YM, Langenberg K, Krijgsveld J, Heck AJ, Karch F and Verrijzer CP. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol Cell. 2005; 17(5):695-707.
43. Felle M, Joppien S, Nemeth A, Diermeier S, Thalhammer V, Dobner T, Kremmer E, Kappler R and Langst G. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res. 2011; 39(19):8355-8365.
44. Ma H, Chen H, Guo X, Wang Z, Sowa ME, Zheng L, Hu S, Zeng P, Guo R, Diao J, Lan F, Harper JW, Shi YG, Xu Y and Shi Y. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc Natl Acad Sci U S A. 2012; 109(13):4828-4833.
45. Oh YM, Yoo SJ and Seol JH. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity. Biochem Biophys Res Commun. 2007; 357(3):615-619.
46. Giovinazzi S, Morozov VM, Summers MK, Reinhold WC and Ishov AM. USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase. Cell Death Differ. 2013.
47. Gisselsson D. Classification of chromosome segregation errors in cancer. Chromosoma. 2008; 117(6):511-519.
48. Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD and Thomas P. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 2010; 26(1):125-132.
49. Cimini D, Fioravanti D, Salmon ED and Degrassi F. Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells. J Cell Sci. 2002; 115(Pt 3):507-515.
50. Norppa H and Falck GC. What do human micronuclei contain? Mutagenesis. 2003; 18(3):221-233.
51. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S and Zeiger E. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res. 2003; 534(1-2):65-75.
52. Bakhoum SF, Genovese G and Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol. 2009; 19(22):1937-1942.
53. Bakhoum SF, Thompson SL, Manning AL and Compton DA. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol. 2009; 11(1):27-35.
54. Gisselsson D, Hakanson U, Stoller P, Marti D, Jin Y, Rosengren AH, Stewenius Y, Kahl F and Panagopoulos I. When the genome plays dice: circumvention of the spindle assembly checkpoint and near-random chromosome segregation in multipolar cancer cell mitoses. PLoS One. 2008; 3(4):e1871.
55. To-Ho KW, Cheung HW, Ling MT, Wong YC and Wang X. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells. Oncogene. 2008; 27(3):347-357.
56. Bakhoum SF and Compton DA. Cancer: CINful centrosomes. Curr Biol. 2009; 19(15):R642-645.
57. Zyss D and Gergely F. Centrosome function in cancer: guilty or innocent? Trends Cell Biol. 2009; 19(7):334-346.
58. Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM and Saunders WS. Resolution of anaphase bridges in cancer cells. Chromosoma. 2004; 112(8):389-397.
59. Benavente CA, McEvoy JD, Finkelstein D, Wei L, Kang G, Wang YD, Neale G, Ragsdale S, Valentine V, Bahrami A, Temirov J, Pounds S, Zhang J and Dyer MA. Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget. 2013; 4(6):844-859.
60. Sowa ME, Bennett EJ, Gygi SP and Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009; 138(2):389-403.
61. Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN, Camonis J, Calabrese A, Borg-Capra C, Sippl W, Collura V, Boissy G, Rain JC, et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Molecular cancer therapeutics. 2009; 8(8):2286-2295.
62. Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W and Colland F. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol. 2012; 19(4):467-477.
63. Sudakin V, Chan GK and Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol. 2001; 154(5):925-936.
64. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN and Kirsch IR. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res. 2003; 63(24):8634-8647.
65. Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, et al. Chromosomal instability determines taxane response. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(21):8671-8676.
66. Swanton C, Tomlinson I and Downward J. Chromosomal instability, colorectal cancer and taxane resistance. Cell cycle. 2006; 5(8):818-823.
67. Stegmeier F, Rape M, Draviam VM, Nalepa G, Sowa ME, Ang XL, McDonald ER, 3rd, Li MZ, Hannon GJ, Sorger PK, Kirschner MW, Harper JW and Elledge SJ. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature. 2007; 446(7138):876-881.
68. Zhang Y, Foreman O, Wigle DA, Kosari F, Vasmatzis G, Salisbury JL, van Deursen J and Galardy PJ. USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. J Clin Invest. 2012; 122(12):4362-4374.
69. Nicholson B and Suresh Kumar KG. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys. 2011; 60(1-2):61-68.
70. Colland F. The therapeutic potential of deubiquitinating enzyme inhibitors. Biochem Soc Trans. 2010; 38(Pt 1):137-143.
71. Hollstein M, Sidransky D, Vogelstein B and Harris CC. p53 mutations in human cancers. Science. 1991; 253(5015):49-53.
72. Levine AJ, Momand J and Finlay CA. The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-456.
73. Nakatani Y and Ogryzko V. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 2003; 370:430-444.
74. Giovinazzi S, Lindsay CR, Morozov VM, Escobar-Cabrera E, Summers MK, Han HS, McIntosh LP and Ishov AM. Regulation of mitosis and taxane response by Daxx and Rassf1. Oncogene. 2012.
75. Countryman PI and Heddle JA. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res. 1976; 41(2-3):321-332.
76. Meraldi P and Sorger PK. A dual role for Bub1 in the spindle checkpoint and chromosome congression. EMBO J. 2005; 24(8):1621-1633.
77. Lindsay CR, Giovinazzi S and Ishov AM. Daxx is a predominately nuclear protein that does not translocate to the cytoplasm in response to cell stress. Cell cycle. 2009; 8(10).
78. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J and Pommier Y. CellMiner: a webbased suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012; 72(14):3499-3511.